FDA Commissioner outlines steps to spur biomedical innovation in USA

A blueprint containing immediate steps that can be taken to drive biomedical innovation, while improving the health of Americans was released this week by US Food and Drug Administration Commissioner Margaret Hamburg. Titled “Driving Biomedical Innovation: Initiatives for Improving Products for Patients, this addresses concerns about the sustainability of the medical product development pipeline, which is slowing down despite record investments in research and development.

“The Obama Administration is committed to encouraging the entrepreneurs and businesses that are modernizing and strengthening our health care system,” said Health and Human Services Secretary Kathleen Sebelius, noting that “the innovation blueprint is another part of our effort to help businesses grow and keep Americans healthy.”